Dermal Allograft Augmentation of Large and Massive Rotator Cuff Tears

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age30-75
SponsorArthrex, Inc.

About this trial

The purpose of this study is to compare postoperative healing of large and massive rotator cuff tears with preoperative MRI confirmed fatty infiltration stage II and higher repaired with or without dermal allograft augmentation (DAA).

Eligibility criteria

Qualifiers

The subject is between the ages of 30 and 75 years.

Subject is planning to undergo arthroscopic surgery for full-thickness rotator cuff tear (RCT)

Two complete RCTs or tear size equal to or greater than 3 cm in either the anterior-posterior or medial-lateral dimension

Primary rotator cuff repair

Disqualifiers

The Subject is unable or unwilling to sign the patient informed consent, approved by the Institutional Review Board.

The subject objects to the use of allograft

Stage I or lower fatty infiltration of the supraspinatus AND infraspinatus muscle

Complete full-thickness subscapularis tears of greater than the superior one third of the tendon (Lafosse grade 3 and above)

Trial design

Treatments tested in this trial

  • Repair with DAA (dermal allograft augmentation)

Treatment groups

120 Participants
are divided into 1 treatment group

Sponsors and collaborators